Tiziana Life Sciences Ltd (TLSA)

US · Healthcare · Biotechnology

$0.97+25.97%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Net profit

$-12.8M

EPS

$-0.05

EPS estimate

$0.00

Market cap

$113.3M

Forward P/E

0.0

P/B

2,357.48

Book value

$0.00

EPS (TTM)

$-0.16

52-week high

$2.35

52-week low

$0.87

50-day MA

$1.05

200-day MA

$1.32

Beta

0.45

with an average price target of $8.01.

Insiders

47.65%

Institutions

1.94%

Fund	Stake
Dauntless Investment Group, LLC	1.70%
Mid-American Wealth Advisory Group, Inc.	0.25%
Marshall Wace Asset Management Ltd	0.12%
Zhang Financial LLC	0.10%
UBS Group AG	0.08%
Citadel Advisors Llc	0.06%
The Colony Group LLC	0.06%
Geode Capital Management, LLC	0.06%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tiziana Life Sciences Ltd — free to start.

Data updated 2026-09-18.